Catalyst Wire Dossier Catalyst Wire Dossier

Eligen B12

· Emisphere Technologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eligen B12, covering 2011-03-09 to 2011-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin [NA]

See pricing